We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVRI:NYSEEnviri Corporation Analysis

Data as of 2026-08-21 - not real-time

$20.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Enviri Corporation trades at $20.31, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 11.4%. With RSI at 42.3 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $19.36 and resistance around $24.20.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 41.1% above where the shares trade now. Revenue is contracting at 66.7% on a -24.4% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 47.0%, a beta of 0.95 and a maximum drawdown of 17.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

Enviri Corporation NYSE:NVRI shares slipped slightly in pre-market trading on Tuesday after the company reported a...Strong performance at Harsco Environmental and Rail, with each exceeding expectations in the quarterStrategic decision...Kalkine Media9dEnviri NYSE:NVRI : What Could Today’s Update Reveal About Industrial Environmental Services And Cost...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 19.14
  • MACD momentum is negative
  • 30-day price change of -11.4%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading above the 200-day average of 19.14
  • Analyst targets imply +41.1% versus the current price
  • 30-day volatility of 47.0%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -24.4%
  • Analyst targets imply +41.1% versus the current price
  • Negative return on equity of -78.1%

Key Metrics & Analysis

Financial Health

Revenue Growth-66.70%
Profit Margin-24.38%
P/E Ratio-19.0
ROE-78.08%
ROA-3.83%
Debt/Equity61.56
P/B Ratio0.9
Op. Cash Flow$-202568000
Free Cash Flow$-482875
Industry P/E29.8

Technical Analysis

TrendNeutral
RSI42.3
Support$19.36
Resistance$24.20
MA 20$21.61
MA 50$21.91
MA 200$19.14
MACDBearish
VolumeIncreasing
Fear & Greed Index92.84

Valuation

Target Price$28.67
Upside/Downside41.15%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.95
Volatility47.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.